Epidemiology of Preventable Drug-Related Problems (DRPs) Among Hospitalized Children at KAMC-Jeddah: a Single-Institution Observation Study

IF 2.2 Q2 HEALTH CARE SCIENCES & SERVICES
Aeshah A AlAzmi, Omaima Ahmed, H. Alhamdan, Hanan AlGarni, Rawan Mohammed Elzain, Rihad S AlThubaiti, M. Aseeri, Adnan Al Shaikh
{"title":"Epidemiology of Preventable Drug-Related Problems (DRPs) Among Hospitalized Children at KAMC-Jeddah: a Single-Institution Observation Study","authors":"Aeshah A AlAzmi, Omaima Ahmed, H. Alhamdan, Hanan AlGarni, Rawan Mohammed Elzain, Rihad S AlThubaiti, M. Aseeri, Adnan Al Shaikh","doi":"10.2147/DHPS.S220081","DOIUrl":null,"url":null,"abstract":"Aim Drug-related problems (DRPs) “are the unwanted effects of drugs that potentially lead to a harmful outcome” thereby requiring considerable attention. Hospitalized pediatric patients, in particular, represent a population at risk of DRPs. The epidemiology of preventable DRPs among children in Saudi Arabia remains scarce, which thus poses distinct challenges to all healthcare professionals. We aim to characterize preventable DRPs among hospitalized children at KAMC-Jeddah. Methods A prospective observational study of children (≤15 years) admitted to pediatric units (excluding cancer units) at KAMC-Jeddah over a 3-month period (May 29 to August 30, 2016) is carried out to determine the incidence of preventable DRPs and investigate the possible associated factors (gender, age, admission location, type of admission, and number of medications). Results A total of 319 DRPs were identified among 235 patients, of which 280 DRPs (87.8%, 280/319) were deemed preventable. The majority of preventable DRPs were related to dose selection (78%, 219/280). None of the preventable DRPs were life threatening or fatal, and the majority were assessed as moderate in severity (94.3%, 264/280). There was no significant difference between DRP incidences with age mean 3.5 (P=0.389), gender mean (P=0.436), and weight mean 13.47 (P=0.323). Younger children (age ≤2years) admitted to PICU were more likely to have DRP (OR 4.44, 95% CI, 1.87 to 10.52, P=0.00001). Scheduled admissions were 2.89 times more likely to be exposed to DRP compared to transferred admissions (OR 2.8, 95% CI, 1.83 to 4.70, P=0.005). Additionally, DRP incidences increased proportionally to the number of medications. Conclusion Our data suggest that establishing appropriate prevention strategies towards improvement and safety in medicine use among this vulnerable patient population is a high priority.","PeriodicalId":11377,"journal":{"name":"Drug, Healthcare and Patient Safety","volume":"11 1","pages":"95 - 103"},"PeriodicalIF":2.2000,"publicationDate":"2019-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/DHPS.S220081","citationCount":"10","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug, Healthcare and Patient Safety","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/DHPS.S220081","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 10

Abstract

Aim Drug-related problems (DRPs) “are the unwanted effects of drugs that potentially lead to a harmful outcome” thereby requiring considerable attention. Hospitalized pediatric patients, in particular, represent a population at risk of DRPs. The epidemiology of preventable DRPs among children in Saudi Arabia remains scarce, which thus poses distinct challenges to all healthcare professionals. We aim to characterize preventable DRPs among hospitalized children at KAMC-Jeddah. Methods A prospective observational study of children (≤15 years) admitted to pediatric units (excluding cancer units) at KAMC-Jeddah over a 3-month period (May 29 to August 30, 2016) is carried out to determine the incidence of preventable DRPs and investigate the possible associated factors (gender, age, admission location, type of admission, and number of medications). Results A total of 319 DRPs were identified among 235 patients, of which 280 DRPs (87.8%, 280/319) were deemed preventable. The majority of preventable DRPs were related to dose selection (78%, 219/280). None of the preventable DRPs were life threatening or fatal, and the majority were assessed as moderate in severity (94.3%, 264/280). There was no significant difference between DRP incidences with age mean 3.5 (P=0.389), gender mean (P=0.436), and weight mean 13.47 (P=0.323). Younger children (age ≤2years) admitted to PICU were more likely to have DRP (OR 4.44, 95% CI, 1.87 to 10.52, P=0.00001). Scheduled admissions were 2.89 times more likely to be exposed to DRP compared to transferred admissions (OR 2.8, 95% CI, 1.83 to 4.70, P=0.005). Additionally, DRP incidences increased proportionally to the number of medications. Conclusion Our data suggest that establishing appropriate prevention strategies towards improvement and safety in medicine use among this vulnerable patient population is a high priority.
吉达KAMC住院儿童可预防药物相关问题的流行病学:一项单一机构观察研究
目的药物相关问题(DRP)“是药物的不良影响,可能导致有害结果”,因此需要引起相当大的关注。尤其是住院的儿科患者,代表了有DRP风险的人群。沙特阿拉伯儿童中可预防DRP的流行病学仍然很少,因此对所有医疗专业人员构成了明显的挑战。我们旨在描述吉达KAMC住院儿童中可预防的DRP。方法对KAMC-Jeddah儿科病房(不包括癌症病房)入院的儿童(≤15岁)进行为期3个月(2016年5月29日至8月30日)的前瞻性观察性研究,以确定可预防DRP的发病率,并调查可能的相关因素(性别、年龄、入院地点、入院类型和药物数量)。结果235例患者中共发现319例DRP,其中280例(87.8%,280/319)被认为是可预防的。大多数可预防的DRP与剂量选择有关(78%,219/280)。所有可预防的DRP均无生命危险或致命性,大多数被评估为中度(94.3%,264/280)。DRP的发生率与年龄平均值3.5(P=0.389)、性别平均值0.436(P=0.436)、年龄平均值3.0(P=0.438)和年龄平均值4.0(P=0.448)无显著差异,平均体重13.47(P=0.323)。年龄较小的儿童(年龄≤2岁)入住PICU更有可能发生DRP(OR 4.44,95%CI,1.87至10.52,P=0.00001)。与转诊入院相比,计划入院暴露于DRP的可能性高2.89倍(OR 2.8,95%CI,1.83至4.70,P=0.005)。此外,DRP发生率与药物数量成比例增加。结论我们的数据表明,在这一弱势患者群体中,制定适当的预防策略以改善药物使用并确保其安全性是当务之急。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug, Healthcare and Patient Safety
Drug, Healthcare and Patient Safety HEALTH CARE SCIENCES & SERVICES-
CiteScore
4.10
自引率
0.00%
发文量
24
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信